Home › Investor Directory › Biopharmaceuticals › Series A

Active Series A Biopharmaceuticals Investors (2026)

1 investors currently writing series a checks in Biopharmaceuticals. Synthesized from live platform activity · updated August 2026.

Raising capital in the Biopharmaceuticals space requires finding partners who understand your specific market dynamics. The investors listed here are actively deploying capital and looking for high-growth opportunities with defensible competitive advantages. Series A investors are focused on scaling. They expect proven business models, strong unit economics, and a clear path to dominating a market segment.
Sector: Biopharmaceuticals Stage: Series A + Geography + Check size
MK
Maha Katabi
Biopharmaceuticals
Maha Katabi is a General Partner at Sofinnova Investments focused on development-stage biopharmaceuticals with over two decades of experienc...
Active now
Related
Biopharmaceuticals Pre-Seed investors · Biopharmaceuticals Seed investors · Biopharmaceuticals Angel investors
See which of these 1 fit your startup
Free · under a minute
Get matched free